Agata Cova - Concepedia

Concepedia

Author

Agata Cova

Fondazione IRCCS Istituto Nazionale dei Tumori ORCID

Also Known As

A. Cova, Agata Cova

106

Publications

2.5K

Citations

17

H-Index

36

Concepts

All Affiliations

Fondazione IRCCS Istituto Nazionale dei Tumori Istituto Superiore di Sanità University of Milan Tumori Foundation Istituti di Ricovero e Cura a Carattere Scientifico

AC

About

Agata Cova is an author at Fondazione IRCCS Istituto Nazionale dei Tumori specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	1.2K
2	Immunology	7	7	1.2K
3	Cell Biology	5	5	992
4	Allergy	1	1	597
5	Molecular Biology	1	1	20

Agata Cova

×

21

Publications

2.5K

Citations

17

H-Index

	Year	Citations
Modulation of Microenvironment Acidity Reverses Anergy in Human and Murine Tumor-Infiltrating T Lymphocytes Arianna Calcinotto, Paola Filipazzi, Matteo Grioni, Cancer Research ImmunologyImmune RegulationImmunoeditingImmunologic MechanismImmunotherapeutics	2012	597
Vaccination of Metastatic Melanoma Patients With Autologous Tumor-Derived Heat Shock Protein gp96-Peptide Complexes: Clinical and Immunologic Findings Filiberto Belli, Alessandro Testori, Licia Rivoltini, Journal of Clinical Oncology	2002	385
Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma Veronica Huber, Viviana Vallacchi, Viktor Fleming, Journal of Clinical Investigation Cancer ImmunosurveillanceMdsc FeaturesMdsc ActivityMelanomaImmunology	2018	245
TNF-Related Apoptosis-Inducing Ligand (TRAIL)–Armed Exosomes Deliver Proapoptotic Signals to Tumor Site Licia Rivoltini, Claudia Chiodoni, Paola Squarcina, Clinical Cancer Research	2016	182
Natural-Killer-Derived Extracellular Vesicles: Immune Sensors and Interactors Cristina Federici, Eriomina Shahaj, Serena Cecchetti, Frontiers in Immunology	2020	149
A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-α in metastatic melanoma patients Lorenzo Pilla, Roberto Patuzzo, Licia Rivoltini, Cancer Immunology Immunotherapy Tumor ImmunologyCancer ImmunosurveillancePhase Ii TrialMedicineMelanoma	2005	137
Human Tumor-Derived Heat Shock Protein 96 Mediates In Vitro Activation and In Vivo Expansion of Melanoma- and Colon Carcinoma-Specific T Cells Licia Rivoltini, Chiara Castelli, Matteo Giovanni Carrabba, The Journal of Immunology	2003	120
Immunization of Stage IV Melanoma Patients with Melan-A/MART-1 and gp100 Peptides plus IFN-α Results in the Activation of Specific CD8+ T Cells and Monocyte/Dendritic Cell Precursors Tiziana Di Pucchio, Lorenzo Pilla, Imerio Capone, Cancer Research	2006	115
Role of Cross-Talk between IFN-α-Induced Monocyte-Derived Dendritic Cells and NK Cells in Priming CD8+ T Cell Responses against Human Tumor Antigens Diégo Tosi, Roberta Valenti, Agata Cova, The Journal of Immunology Adaptive Immune SystemImmunologyImmune RegulationImmunodominanceImmunologic Mechanism	2004	92
Circulating mir‐320a promotes immunosuppressive macrophages M2 phenotype associated with lung cancer risk Orazio Fortunato, Cristina Borzi, Massimo Milione, International Journal of Cancer	2018	74

Page 1